The Latest Breaking News from Kritika SarmahHer

The solid annual gain in retail sales and the strong demand for luxury goods in the U.S. point to a thriving fashion industry. However, let us analyze whether popular fashion stocks Abercrombie & Fitch (ANF) and Ross Stores (ROST) are ideal investment opportunities.

Solid global demand for oil & gas and tight supplies amid OPEC+ extended production cuts and enhanced geopolitical instability are boosting energy prices. Hence, investors could keep an eye on promising energy stocks Dorchester Minerals (DMLP), Profire Energy (PFIE), and Permianville Royalty (PVL) poised for success. Read more….

The strong US economic expansion in 2023, surpassing GDP estimates, is expected to benefit the financial industry by boosting lending, investment activity, and profitability for financial institutions. Hence, fundamentally solid financial stocks ORIX Corporation (IX), FLEETCOR Technologies (FLT), and Jiayin Group (JFIN) might be ideal buys for solid gains. Read…

Amidst escalating geopolitical tensions and rising global oil demand, the energy industry is flourishing. Hence, fundamentally solid energy stocks Western Midstream Partners (WES), NuStar Energy (NS), and Graham Corporation (GHM) might be ideal buys. Read more.

Despite the push toward electrification and anticipation of higher vehicle sales this year, the automotive industry grapples with several macroeconomic uncertainties. Amid this, let’s analyze whether it would be wise to add Tesla (TSLA) and Ford Motor (F) to your portfolio this month. Read more to find out.

The biotech industry is thriving on growing applications across sectors from healthcare to agriculture, favorable government funding and policies, and technological breakthroughs. Amid this backdrop, quality biotech stocks UroGen Pharma (URGN), Foghorn Therapeutics (FHTX), and Galapagos (GLPG) might be ideal additions to one’s watchlist. Read on….

Amid rising healthcare demand globally, advancements in precision medicine, and the booming e-pharmacy market, the pharmaceutical industry is expected to witness significant long-term growth. Hence, fundamentally sound pharma stocks Dr. Reddy’s Laboratories (RDY), Ipsen (IPSEY), and Johnson & Johnson (JNJ), which boast low beta values and attractive valuation metrics, might…

The biotech industry is poised for groundbreaking advancements, driving transformative innovations in drug discovery and therapeutic interventions. Hence, fundamentally strong biotech stocks Immunocore Holdings (IMCR), Halozyme Therapeutics (HALO), and Entrada Therapeutics (TRDA) might be ideal buys for long-term return. Read more….

Fueled by the surging demand for chips in AI, high-performance computing, smartphones, and automotive applications, the chip market is poised for recovery this year. However, while it might be ideal to buy fundamentally sound chip stocks QUALCOMM (QCOM) and Everspin Technologies (MRAM) next month, avoiding Indie Semiconductor (INDI) is advised,…

The automotive industry is evolving rapidly, with innovations in electric vehicles, AI, and auto parts driving growth and enhancing efficiency. Hence, quality auto stocks PACCAR (PCAR), Gates Industrial (GTES), and Garrett Motion (GTX) might be ideal investments. Read more….

The surge in semiconductor demand, coupled with ongoing innovation and government initiatives, positions the semiconductor industry for substantial growth and technological advancement in the coming years. Hence, it might be prudent to invest in fundamentally solid semiconductor stocks Taiwan Semiconductor Manufacturing (TSM), ASE Technology Holding (ASX), and United Microelectronics (UMC).…